Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.029359 | 1 | 1 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.029359 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0102475 | 0.280464 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0102475 | 0.280464 | 1 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0102475 | 0.280464 | 1 |
Loa Loa (eye worm) | CYP4Cod1 | 0.00426615 | 0.0552677 | 0.0552677 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0102475 | 0.280464 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0102475 | 0.280464 | 0.23837 |
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.0102475 | 0.280464 | 1 |
Schistosoma mansoni | hypothetical protein | 0.029359 | 1 | 1 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0102475 | 0.280464 | 1 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0102475 | 0.280464 | 1 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.029359 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0102475 | 0.280464 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0102475 | 0.280464 | 1 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.029359 | 1 | 1 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0102475 | 0.280464 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0102475 | 0.280464 | 0.280464 |
Leishmania major | hypothetical protein, conserved | 0.0102475 | 0.280464 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0102475 | 0.280464 | 0.23837 |
Loa Loa (eye worm) | hypothetical protein | 0.0102475 | 0.280464 | 0.280464 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.029359 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.029359 | 1 | 1 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.029359 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0102475 | 0.280464 | 0.280464 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0102475 | 0.280464 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0102475 | 0.280464 | 1 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.00426615 | 0.0552677 | 0.5 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.00426615 | 0.0552677 | 0.0552677 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0102475 | 0.280464 | 0.23837 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.029359 | 1 | 1 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.029359 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0102475 | 0.280464 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.029359 | 1 | 0.5 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0102475 | 0.280464 | 1 |
Schistosoma mansoni | brg-1 associated factor | 0.029359 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.029359 | 1 | 1 |
Onchocerca volvulus | 0.029359 | 1 | 1 | |
Trypanosoma brucei | hypothetical protein, conserved | 0.0102475 | 0.280464 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0102475 | 0.280464 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.029359 | 1 | 0.5 |
Brugia malayi | YY1-associated factor 2 | 0.0102475 | 0.280464 | 0.23837 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0102475 | 0.280464 | 0.23837 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0102475 | 0.280464 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0102475 | 0.280464 | 0.280464 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.029359 | 1 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.00426615 | 0.0552677 | 0.0552677 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.029359 | 1 | 1 |
Loa Loa (eye worm) | brahma associated protein | 0.029359 | 1 | 1 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.029359 | 1 | 0.5 |
Chlamydia trachomatis | SWIB complex protein | 0.029359 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.029359 | 1 | 1 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.029359 | 1 | 1 |
Brugia malayi | brahma associated protein 60 kDa | 0.029359 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0102475 | 0.280464 | 0.280464 |
Brugia malayi | brahma associated protein 60 kDa | 0.029359 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0102475 | 0.280464 | 1 |
Chlamydia trachomatis | DNA topoisomerase I | 0.029359 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 5 ug ml-1 | Antimicrobial activity against Plasmodium falciparum TM91C235 by microdilution method | ChEMBL. | 21282058 |
IC50 (functional) | > 5 ug ml-1 | Antimicrobial activity against Plasmodium falciparum D6 by microdilution method | ChEMBL. | 21282058 |
IC50 (functional) | > 5 ug ml-1 | Antimicrobial activity against Plasmodium falciparum W2 by microdilution method | ChEMBL. | 21282058 |
MED (functional) | > 160 mg/kg/day | Antiplasmodial activity against Plasmodium berghei sporozoites infected in orally dosed mouse administered for three consecutive days one day before infection | ChEMBL. | 21282058 |
MTD (ADMET) | >= 160 mg/kg/day | Toxicity in Plasmodium berghei sporozoites infected orally dosed mouse administered for three consecutive days one day before infection | ChEMBL. | 21282058 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | 21282058 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.